Eli Lilly and Company
Amino pyrimidine ssao inhibitors

Abstract:

The present invention provides compounds of the Formula (I), or a pharmaceutically acceptable salt thereof, where n and R1 are defined herein, methods of treating patients for liver disease, and processes for preparing the compounds.